Intro In this special episode of White Coat Black Sheep, Dr. Civelli isn't hosting, she's the guest speaker. She joined Empire Medical Training's live peptide webinar alongside Dr. Chris Crowley, Empire's Chief Medical Officer, with founder Dr. Steven Cosentino opening the session. Together they break down what peptides actually are, which ones are FDA approved versus banned versus somewhere in between, and the legal, insurance, and advertising realities that come with offering peptide therapy in a practice. Topics Covered What a peptide is, structurally and functionallyThe four major peptide categories in demand right now: healing (BPC-157, TB-500), weight loss (GLP-1s), cognitive/longevity, and skinThe angiogenesis and undiagnosed cancer risk question with BPC-157Why her malpractice insurance premium doubled after disclosing peptide prescribingThe real meaning behind peptides being called banned, and the difference between FDA approved, removed from the prohibited list, and still prohibitedThe FDA's April 2026 removal of six peptides from the prohibited category and what still has to happen before they're fully approvedWhether compounded medications are still considered unsafe, and how to vet a compounding pharmacyTwo real legal cases involving unapproved peptide distribution and their consequencesBuilding effective, synergistic peptide stacks without overwhelming a patientHow to find and work with a healthcare attorney who helps you find compliant paths forward instead of just saying noFDA rules around advertising peptide therapy without making unsubstantiated claimsHow peptide regulation differs by state, with Florida cited as more peptide friendly than much of the SoutheastThe legal exposure of mid-level providers selling peptides without proper physician oversightMentioned in Episode BPC-157 and TB-500, together known as the Wolverine StackGLP-1 peptides: Semaglutide, Tirzepatide, RetatrutideCognitive and longevity peptides, including Semax, Selank, and EpithalonGHK-Cu, a copper peptide used for skinThe FDA's April 2026 removal of six peptides from its prohibited compounding categoryUSP 797, the federal compounding lawByrd Adatto, a healthcare and med spa focused law firmCompounding pharmacy partners referenced: Empower Pharmacy, Olympia, and Anazao HealthJournal of Peptide Science and Peptides as ongoing research resourcesEmpire Medical Training's peptide certification course pathwayConnect with Dr. Civelli Trifecta Medical | trifectamedical.org 7702 Meany Ave #101, Bakersfield, CA 93308 (661) 677-2623 | info@trifectamedical.org Personal brand: www.houseofval.com Instagram: @drcivelli Services: HRT, Peptides, Health Optimization, Botox, IV Hydration, Functional Medicine, Dermatology, Aesthetics, Regenerative Medicine, Hair Loss Treatments, Psychiatry, Clinical Trials